ABCC1, ABCG2 and FOXP3: Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis

Background: Methotrexate (MTX) is one of the most extensively used drugs in the treatment of moderate-to-severe psoriasis (PS). However, it frequently must be suspended owing to the toxicity in certain patients. Objective: To evaluate the influence of ABCC1, ABCG2, and FOXP3 in the development of MT...

Descripción completa

Detalles Bibliográficos
Autores principales: Membrive-Jiménez, Cristina, Vieira-Maroun, Sayleth, Márquez-Pete, Noelia, Cura, Yasmin, Pérez-Ramírez, Cristina, Tercedor-Sánchez, Jesús, Jiménez-Morales, Alberto, Ramírez-Tortosa, María del Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526923/
https://www.ncbi.nlm.nih.gov/pubmed/37761008
http://dx.doi.org/10.3390/biomedicines11092567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526923/
https://www.ncbi.nlm.nih.gov/pubmed/37761008
http://dx.doi.org/10.3390/biomedicines11092567

Ejemplares similares